Patrick Round

Chief Medical Officer

2024 - Current

Venture Partner

2018

Chief Executive Officer

2015

Chief Medical Officer

2009

Responsible for all preclinical, clinical and manufacturing of Xention development projects via the virtual development model using third party providers. Xention specialises in drugs that modulate ion channels. Therapeutic areas; atrial fibrillation, cough (via Provesica) and dyslipidaemia (via Dezima)

Independent Consultant

2008

Providing clinical and general development support for biotechnology companies

Medical Director

2015 - 2024

Project Pysician

2023 - 2024

Chief Medical Officer

2021 - 2024

Chief Medical Officer

2017 - 2021

Chief Medical Officer

2007 - 2008

Responsible for all the clinical and regulatory development activities for Chronocort, a delayed sustained release formulation of hydrocortisone for patients with Congenital Adrenal Hyperplasia and Addison's disease, using a novel tablet coating technology. Phoqus operated a Virtual Development model using third party providers and external consultants.

Senior Vice President

2004 - 2007

Line management of the CAT Development functions of about 100 staff plus contractors: Manufacturing Process Development, Quality, Regulatory, Clinical Development, and Project Management based in Cambridge UK, a Development team of 17 in Palo Alto CA. Operational accountability for 60 manufacturing process development staff in AZ Sweden